Fabian Theis, Director of the Computational Health Center at Helmholtz Munich, has been accepted for membership in the European Molecular Biology Organization (EMBO). Scientists can only be invited to join EMBO on the recommendation of existing…
Computer systems can already independently analyze health data, learn from it and even derive therapy recommendations. Which opportunities this means for patients and what research needs to apply artificial intelligence in practice.
Two newly acquired ERC Advanced Grants support the cutting-edge research of Munich Helmholtz scientists Heiko Lickert and Fabian Theis. The researchers are international stars in the fields of diabetes and artificial intelligence. The funding will…
Data is not only the answer to numerous questions in the business world; the same applies to biomedical research. In order to develop new therapies or prevention strategies for diseases, scientists need more and better data, faster and faster.…
The interplay of genetics and epigenetics is a long-sought riddle in the development of diseases. Researchers from Helmholtz Munich and the Imperial College London discovered novel interactions. Their findings improve our knowledge about…
For the first time, scientists based at Helmholtz Munich and the University of Oxford were able to shed light on one of the most critical stages of human embryonic development (gastrulation). The finding, published in the journal Nature, will…
We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here: